Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H LUDWIG

Showing results (301-310 of 756) with videos related to

Pageof 76
Sort By:
Stem Cells (Dayton, Ohio)|August 1, 1995
Increase of bone marrow cellularity during erythropoietin treatment in myelomaH Ludwig, A Chott, E Fritz, et al.
Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete|October 15, 1976
[Age-corrected analysis of glucose tolerance in blood relations of patients with juvenile onset diabetes mellitus]G Schernthaner, H Ludwig, K Silberbauer, et al.
Acta Medica Austriaca|January 1, 1975
[Autoimmune phenomena in D-penicillamine therapy]G Kolarz, H Ludwig, M Sabeti, et al.
Oncology|January 1, 1989
Phase II evaluation of 5-fluorouracil, folinic acid and cisplatin in advanced-stage colorectal adenocarcinomaW Scheithauer, D Depisch, R Schiessel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2002
A paraneoplastic syndrome mimicking extrauterine pregnancyP Sagaster, N Zojer, G Dekan, et al.
Blood|August 1, 1986
Shortened platelet half-life in multiple myelomaE Fritz, H Ludwig, W Scheithauer, et al.
Blut|February 1, 1985
Multiple myeloma and primary hyperparathyroidismN Mian, J Kovarik, W Woloszczuk, et al.
Plos One|October 13, 2023
Decision avoidance and post-decision regret: A systematic review and meta-analysisQing Han, Susanne Quadflieg, Casimir J H Ludwig
Journal of Biological Regulators and Homeostatic Agents|April 1, 1988
Experiences with continuous intraarterial administration of recombinant interferon alpha-2C (rIFN-alpha 2) for treatment of patients with advanced transitional cell bladder cancerW Scheithauer, G Theyer, O Zechner, et al.
Cognitive Research: Principles and Implications|August 4, 2023
Graded prioritisation of targets in search: reward diminishes the low prevalence effectVeronica Hadjipanayi, Casimir J H Ludwig, Christopher Kent
Pageof 76

Showing results (301-310 of 756) with videos related to

Sort By:
Pageof 76
Stem Cells (Dayton, Ohio)|August 1, 1995
Increase of bone marrow cellularity during erythropoietin treatment in myelomaH Ludwig, A Chott, E Fritz, et al.
Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete|October 15, 1976
[Age-corrected analysis of glucose tolerance in blood relations of patients with juvenile onset diabetes mellitus]G Schernthaner, H Ludwig, K Silberbauer, et al.
Acta Medica Austriaca|January 1, 1975
[Autoimmune phenomena in D-penicillamine therapy]G Kolarz, H Ludwig, M Sabeti, et al.
Oncology|January 1, 1989
Phase II evaluation of 5-fluorouracil, folinic acid and cisplatin in advanced-stage colorectal adenocarcinomaW Scheithauer, D Depisch, R Schiessel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2002
A paraneoplastic syndrome mimicking extrauterine pregnancyP Sagaster, N Zojer, G Dekan, et al.
Blood|August 1, 1986
Shortened platelet half-life in multiple myelomaE Fritz, H Ludwig, W Scheithauer, et al.
Blut|February 1, 1985
Multiple myeloma and primary hyperparathyroidismN Mian, J Kovarik, W Woloszczuk, et al.
Plos One|October 13, 2023
Decision avoidance and post-decision regret: A systematic review and meta-analysisQing Han, Susanne Quadflieg, Casimir J H Ludwig
Journal of Biological Regulators and Homeostatic Agents|April 1, 1988
Experiences with continuous intraarterial administration of recombinant interferon alpha-2C (rIFN-alpha 2) for treatment of patients with advanced transitional cell bladder cancerW Scheithauer, G Theyer, O Zechner, et al.
Cognitive Research: Principles and Implications|August 4, 2023
Graded prioritisation of targets in search: reward diminishes the low prevalence effectVeronica Hadjipanayi, Casimir J H Ludwig, Christopher Kent
Pageof 76